Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05882734
Title	Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322)
Recruitment	Active, not recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	EMD Serono Research & Development Institute, Inc.
Indications	lung non-squamous non-small cell carcinoma
Therapies	Cemiplimab + M1774
Age Groups:	adult \| senior
Covered Countries	USA \| ITA \| FRA \| ESP \| DEU \| BEL